X hits on this document

PDF document

RADIESSETM INJECTABLE FILLER PROVIDES 12-MONTH IMPROVEMENT OF VOCAL FOLD INSUFFICIENCY IN MULTICENTE... - page 2 / 2

13 views

0 shares

0 downloads

0 comments

2 / 2

and don’t meet together to close the middle opening completely (usually due to muscle damage or muscle loss associated with aging).

Key findings based on more than 50 study patients at the 12-month time point include:

  • 73% of patients reported their voice was greatly or significantly improved 12 months after injection.

  • The mean voice handicap index scores, a standard assessment tool used to measure vocal recovery, were improved at the 12-month follow-up time point.

  • Objective voice testing of maximum phonation test, a measure of how long a person can say “ah” on one breath showed a statistically significant improvement comparing pre- treatment and the 12-month follow-up time points.

About Radiesse Manufactured and distributed in the U.S. by BioForm Medical, Inc., Radiesse is an injectable filler used in various cosmetic, reconstructive and ENT applications to augment and contour folds, depressions and vocal fold defects of the facial area. Composed of tiny calcium hydroxylapatite (CaHA) particles suspended in a water-based gel carrier, Radiesse has been proven safe and biocompatible in numerous soft tissue applications. Among the product’s many advantages, Radiesse treatment allows steady growth of collagen matrix, produces virtually

instant results, and lasts one to three years. www.radiesse.com.

For more information, please visit

About BioForm Medical, Inc.

Headquartered in San Mateo, CA, BioForm Medical, Inc., is a privately-held medical device company developing and commercializing injectable implant products for soft and hard tissue augmentation and topical preparations for dermatological conditions. The Company is dedicated to improving patients’ lives by providing high quality, innovative, safe and effective medical products for use in the plastic surgery, dermatology, urology, and ENT markets. For more information about BioForm, please visit the Company’s website at www.bioformmedical.com.

For more information, contact: NDTosk Communications for Radiesse Karen Sideris, 219.922.7537 kmssgs@msn.com or Nadine Tosk, 847.920.9858 nadinepr@bellsouth.net

Document info
Document views13
Page views13
Page last viewedWed Dec 07 22:30:55 UTC 2016
Pages2
Paragraphs23
Words739

Comments